Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study

BACKGROUND: Esaxerenone has potential renoprotective effects and reduces the urinary albumin-to-creatinine ratio (UACR) in patients with diabetic kidney disease and overt nephropathy. We investigated the efficacy and safety of esaxerenone in Japanese patients with type 2 diabetes (T2D) and macroalbu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Sadayoshi, Kashihara, Naoki, Shikata, Kenichi, Nangaku, Masaomi, Wada, Takashi, Okuda, Yasuyuki, Sawanobori, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421271/
https://www.ncbi.nlm.nih.gov/pubmed/34110524
http://dx.doi.org/10.1007/s10157-021-02075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421271/
https://www.ncbi.nlm.nih.gov/pubmed/34110524
http://dx.doi.org/10.1007/s10157-021-02075-y

Ejemplares similares